- Report
- October 2023
- 145 Pages
Global
From €3033EUR$3,150USD£2,609GBP
- Report
- November 2023
- 76 Pages
France
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 90 Pages
Malaysia
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 73 Pages
India
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 74 Pages
Egypt
From €3371EUR$3,500USD£2,899GBP
- Report
- February 2023
- 115 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Report
- November 2023
- 80 Pages
Germany
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2022
- 120 Pages
Global
From €4574EUR$4,750USD£3,934GBP
- Report
- October 2023
- 146 Pages
Global
From €3397EUR$3,528USD£2,922GBP
€3996EUR$4,150USD£3,437GBP
- Report
- March 2022
Global
From €4671EUR$4,850USD£4,017GBP
- Report
- March 2021
Japan, Europe, United States Japan, Europe, United States
From €915EUR$950USD£787GBP
- Report
- February 2020
United States, Europe, ... United States, Europe, Japan
From €915EUR$950USD£787GBP
The Blood Urea Nitrogen (BUN) Test is a type of In Vitro Diagnostics (IVD) test used to measure the amount of urea nitrogen in the blood. Urea nitrogen is a waste product of protein metabolism, and its levels in the blood can indicate kidney function. The BUN Test is used to diagnose and monitor kidney diseases, as well as to assess the effectiveness of dialysis treatments. It is also used to evaluate the effectiveness of certain medications, such as antibiotics and diuretics.
The BUN Test market is a subset of the larger IVD market, which is composed of a variety of diagnostic tests used to detect and monitor diseases. The BUN Test market is highly competitive, with a number of companies offering a range of products. These products include automated analyzers, reagents, and kits.
Some of the major companies in the BUN Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Sysmex Corporation. Show Less Read more
